健喬信元醫藥生技股份有限公司
健喬信元醫藥生技股份有限公司(Synmosa Biopharma Corporation)研發製造並分銷藥品與保健品。專注於心血管、呼吸道、泌尿科及癌症藥物。提供噴鼻劑、定量噴霧吸入器及發泡錠。公司成立於 1970 年,總部位於台灣台北。
該股 RSI(6) 為 35.6,處於中性區間,短線無明顯超買超賣訊號。股價跌破5日、20日、60日、120日均線。短中期均線呈空頭排列,趨勢偏空。KD 指標中性(K=33.6);MACD 柱狀體歸零,多空方向不明。 (自動產生 · 非投資建議)
| 日期 | 外資 | 投信 | 自營商 | 合計 |
|---|---|---|---|---|
| 09-24 | -186 | 0 | +6 | -188 |
| 09-23 | +104 | 0 | 0 | +104 |
| 09-22 | +150 | 0 | 0 | +150 |
| 09-21 | +53 | 0 | 0 | +52 |
| 09-18 | +228 | 0 | 0 | +227 |
| 09-17 | +338 | 0 | +7 | +341 |
| 09-16 | -55 | 0 | 0 | -55 |
| 09-15 | +69 | 0 | +2 | +69 |
| 09-14 | -24 | 0 | +4 | -27 |
| 09-11 | -105 | 0 | +14 | -106 |
| 09-10 | +43 | 0 | 0 | +40 |
| 09-09 | +161 | 0 | 0 | +161 |
| 09-08 | +194 | 0 | 0 | +115 |
| 09-07 | -54 | 0 | +4 | -58 |
| 09-04 | +160 | 0 | +9 | +160 |
| 09-03 | -64 | 0 | 0 | -64 |
| 09-02 | +6 | 0 | +6 | +2 |
| 09-01 | -3 | 0 | +2 | -10 |
| 08-31 | -113 | 0 | 0 | -113 |
| 08-28 | +48 | 0 | +4 | +49 |
| 08-27 | -97 | 0 | +16 | -99 |
| 08-26 | -16 | 0 | +18 | -17 |
| 08-25 | -393 | 0 | +36 | -392 |
| 08-24 | +16 | 0 | +1 | +14 |
| 08-21 | -549 | 0 | +1 | -555 |
| 08-20 | +2,030 | 0 | +109 | +2,092 |
| 08-19 | +822 | 0 | +2 | +689 |
| 08-18 | +565 | 0 | +2 | +565 |
| 08-17 | +587 | 0 | +66 | +651 |
| 08-14 | +100 | 0 | +41 | +141 |
| 08-13 | +284 | 0 | +64 | +347 |
| 08-12 | -459 | 0 | +8 | -458 |
| 08-11 | +874 | 0 | +2 | +872 |
| 08-10 | -13 | 0 | +12 | -9 |
| 08-07 | +334 | 0 | +2 | +335 |
| 08-06 | -178 | 0 | +2 | -178 |
| 08-05 | -273 | 0 | +4 | -274 |
| 08-04 | +164 | 0 | +4 | +164 |
| 08-03 | 0 | 0 | +4 | -1 |
| 07-31 | -1,212 | 0 | +22 | -1,212 |
| 07-30 | +201 | 0 | +5 | +202 |
| 07-29 | -56 | 0 | +31 | -84 |
| 07-28 | -62 | 0 | +10 | -79 |
| 07-27 | -700 | 0 | +10 | -701 |
| 07-24 | -5 | 0 | +8 | -6 |
| 07-23 | -631 | 0 | +26 | -631 |
| 07-22 | -483 | 0 | +18 | -484 |
| 07-21 | -598 | 0 | +18 | -597 |
| 07-20 | -366 | 0 | +46 | -370 |
| 07-17 | -1,916 | 0 | +60 | -2,078 |
| 07-16 | -486 | 0 | +250 | -470 |
| 07-15 | +814 | 0 | +15 | +821 |
| 07-14 | +827 | 0 | +5 | +814 |
| 07-13 | +132 | 0 | +38 | +149 |
| 07-09 | +350 | 0 | +33 | +359 |
| 07-08 | -64 | 0 | +81 | +15 |
| 07-07 | +763 | 0 | +90 | +853 |
| 07-06 | +1,403 | 0 | +14 | +1,410 |
| 07-03 | +1,392 | 0 | 0 | +1,392 |
| 07-02 | +8 | 0 | +2 | +6 |
| 07-01 | -200 | 0 | 0 | -200 |
| 06-30 | -401 | 0 | +2 | -400 |
| 06-29 | +735 | 0 | 0 | +735 |
| 06-26 | -638 | 0 | +46 | -638 |
| 06-25 | -88 | 0 | +2 | -88 |
| 06-24 | +595 | 0 | 0 | +595 |
| 06-23 | +590 | 0 | 0 | +580 |
| 06-22 | -245 | 0 | 0 | -245 |
| 06-18 | +160 | 0 | 0 | +160 |
| 06-17 | +63 | 0 | 0 | +63 |
| 06-16 | -54 | 0 | 0 | -54 |
| 06-15 | +312 | 0 | 0 | +312 |
| 06-12 | +485 | 0 | 0 | +485 |
| 06-11 | -309 | 0 | +16 | -308 |
| 06-10 | +42 | 0 | +2 | +42 |
| 06-09 | -39 | 0 | +4 | -38 |
| 06-08 | +156 | 0 | +8 | +155 |
| 06-05 | +202 | 0 | +4 | +204 |
| 06-04 | -332 | 0 | 0 | -332 |
| 06-03 | -126 | 0 | 0 | -126 |
| 06-02 | +110 | 0 | +2 | +110 |
| 06-01 | -66 | 0 | +4 | -66 |
| 05-29 | -53 | 0 | 0 | -53 |
| 月份 | 營收 | MoM% | YoY% |
|---|---|---|---|
| 2026/04 | 5.70 億 | +1.4% | +13.5% |
| 2026/03 | 5.63 億 | +30.8% | +17.3% |
| 2026/02 | 4.30 億 | -32.2% | -7.8% |
| 2026/01 | 6.35 億 | +16.8% | +25.4% |
| 2025/12 | 5.44 億 | +8.2% | +4.3% |
| 2025/11 | 5.03 億 | -7.4% | +0.9% |
| 2025/10 | 5.43 億 | +0.8% | +9.2% |
| 2025/09 | 5.39 億 | +7.0% | +21.7% |
| 2025/08 | 5.03 億 | +1.6% | +2.0% |
| 2025/07 | 4.95 億 | -13.8% | +1.3% |
| 2025/06 | 5.75 億 | +8.0% | +51.5% |
| 2025/05 | 5.32 億 | - | +10.2% |